Jared Fine
Trusted adviser to emerging companies and the venture capital funds that invest in them. His focus on tech includes AI, digital health and fintech.
Jared has significant experience advising a wide range of emerging companies and the venture capital funds that invest in them. His practice spans every stage of the business life cycle.
Emerging companies rely on Jared’s guidance on funding rounds, M&A transactions, public offerings, and general corporate and governance matters. He has a proven record of advising companies from initial financing through successful IPO or exit, while counseling VC firms on all aspects of their investments. Jared has a particular focus on technology, including artificial intelligence, digital health, fintech, enterprise software, consumer tech, robotics and cybersecurity.
Jared’s work in venture capital investments is recognized by Chambers USA. Says a client quoted by Chambers: “He is incredibly knowledgeable and deeply committed to understanding our business needs. He brings a wealth of experience and consistently delivers timely, practical solutions.”
Experience
Prior to joining Davis Polk, Jared’s experience includes advising:
Mergers & Acquisitions
- 6 River Systems in its sale to Shopify
- AppNexus in its sale to AT&T
- Bit9 in its acquisition of Carbon Black
- Brightcove in its acquisitions of Unicorn Media, Zencoder and Ooyala’s online video platform business
- Carevive in its sale to Health Catalyst
- Fincura in its sale to Numerated Growth Technologies
- Handy in its sale to ANGI Homeservices
- HealthEdge in its sale to Blackstone
- Jobcase in its acquisition of Recruitology
- Predilytics in its sale to Welltok
- Solano Labs in its sale to GE Digital
- SpectrumAi in its sale to CentralReach
- Spyce in its sale to Sweetgreen
- TripAdvisor in its acquisition of Jetsetter.com
- Yantriks in its sale to Blue Yonder
IPOs and Other Public Equity Offerings
- Brightcove in its $63 million IPO
- Carbon Black in its $163 million IPO
- HubSpot in its $144 million IPO and $167 million follow-on offering
- Semrush in its $140 million IPO and $103 million follow-on offering
- Underwriters in Endurance International Group’s $252 million IPO and subsequent equity offerings
- Underwriters in Flywire’s $288 million IPO and $256 million follow-on offering
- Underwriters in Intercept Pharmaceuticals’ $86 million IPO
Private Financings
- Aspen RxHealth in its $23 million Series B financing
- Bessemer Venture Partners in numerous portfolio company investments
- Carbon Black in its preferred stock financings
- CharterUP in its $60 million Series A financing
- Cimulate in its $28 million Series A financing led by Spark Capital
- Cohere Health in its $90 million Series C preferred stock financing led by Temasek
- Flare Capital Partners in numerous portfolio company investments
- General Catalyst in numerous portfolio company investments
- Inbound Health in its $30 million Series B financing
- Jobcase in its $100 million growth equity financing led by PSG
- Lynx FinHealth in its $27 million Series A financing
- Matrix Partners in numerous portfolio company investments
- Openly in its $100 million Series D financing and subsequent growth financing led by Eden Global Partners and Allianz X
- OPT Industries in its preferred stock financings
- Optum Ventures in numerous portfolio company investments
- Ori in its preferred stock financings
- Vizit Labs in its $25 million Series B financing led by Industry Ventures
Recognition
Chambers USA – Private Equity: Venture Capital Investment, Massachusetts
Education
- with honors
- Executive Editor, Connecticut Law Review
- magna cum laude
Prior experience
- Partner, Goodwin Procter, 2016-2025
- Associate, Goodwin Procter, 2010-2016
Qualifications and admissions
- State of New York
- State of Massachusetts